Eight years later, Zimmer Biomet FCPA case ends

Medical devices

Zimmer Biomet Holdings disclosed in a regulatory filing it has reached the end of its monitorship, eight years after resolving parallel settlements with the DOJ and SEC for violations of the Foreign Corrupt Practices Act.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.